Tesamorelin

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to stimulate the production and release of natural growth hormone from the pituitary gland. It is FDA-approved for the reduction of excess abdominal fat (visceral adipose tissue) in individuals with HIV-associated lipodystrophy. Tesamorelin works by enhancing metabolism, improving fat distribution, and supporting lean body mass. It is also being explored for its potential benefits in general fat reduction, metabolic health, and age-related hormonal decline. Its targeted mechanism makes it a promising option for specific therapeutic and wellness applications.

Research-Based Only